Publications by authors named "Jakub Jarmula"

Article Synopsis
  • The study focuses on the effectiveness of adjuvant radiation therapy, specifically intensity-modulated radiation therapy (IMRT) and stereotactic radiosurgery (SRS), after subtotal resection of WHO grade II meningiomas due to the limited existing research.
  • A retrospective analysis of 39 patients revealed 3-, 5-, and 10-year progression-free survival rates of 81.1%, 61.2%, and 44.6%, respectively, demonstrating overall acceptable control rates.
  • No significant differences were found in progression-free survival or radiation necrosis occurrences between the IMRT and SRS groups, suggesting both treatments are similarly effective for managing residual tumors.
View Article and Find Full Text PDF
Article Synopsis
  • Scientists studied why some patients lose a lot of blood during surgery for a brain tumor called meningioma.
  • They found that certain things, like how big the tumor is and its location, can help predict how much blood loss will happen.
  • Knowing these factors can help doctors prepare better before the surgery, keeping patients safer.
View Article and Find Full Text PDF

Primary central nervous system (CNS) tumors affect tens of thousands of patients each year, and there is a significant need for new treatments. Macrophage migration inhibitory factor (MIF) is a cytokine implicated in multiple tumorigenic processes such as cell proliferation, vascularization, and immune evasion and is therefore a promising therapeutic target in primary CNS tumors. There are several MIF-directed treatments available, including small-molecule inhibitors, peptide drugs, and monoclonal antibodies.

View Article and Find Full Text PDF

Many cancers, including glioblastoma (GBM), have a male-biased sex difference in incidence and outcome. The underlying reasons for this sex bias are unclear but likely involve differences in tumor cell state and immune response. This effect is further amplified by sex hormones, including androgens, which have been shown to inhibit anti-tumor T cell immunity.

View Article and Find Full Text PDF

Background: Readmissions are major healthcare expenditures, key hospital metrics, and are often preceded by an evaluation in the emergency department (ED). The purpose of this study was to analyze ED visits within 30 days of endoscopic skull base surgery (ESBS), risk factors for readmission once in the ED, and ED-related evaluation and outcomes.

Methods: Retrospective review from January 2017 to December 2022 at a high-volume center of all ESBS patients who presented to the ED within 30 days of surgery.

View Article and Find Full Text PDF

Background: Patients with trigeminal neuralgia (TN) secondary to mass lesions are typically treated by directly addressing the underlying pathology. In cases of TN not alleviated by treatment of the pathology, percutaneous balloon compression (PBC) and glycerol rhizotomy (Gly) are simple and effective ways to alleviate pain. However, there is limited literature on the use of these techniques for patients with TN caused by mass lesions.

View Article and Find Full Text PDF

Background: The increase in use of targeted systemic therapies in cancer treatments has catalyzed the importance of identifying patient- and tumor-specific somatic mutations, especially regarding metastatic disease. Mutations found to be most prevalent in patients with metastatic breast cancer include TP53, PI3K, and CDH1.

Objective: To determine the incidence of somatic mutations in patients with metastatic breast cancer to the spine (MBCS).

View Article and Find Full Text PDF

Background: We previously published a novel strategy for management of postcraniotomy bone flap infection consisting of single stage debridement, bone flap removal, and immediate titanium mesh cranioplasty.

Methods: Postcraniotomy patients with surgical site infections treated with surgical debridement, bone flap removal, and immediate titanium mesh cranioplasty were retrospectively reviewed. The primary outcome measure was reoperation due to persistent infection or wound healing complications from the titanium mesh.

View Article and Find Full Text PDF

Skull base surgery has undergone significant progress following key technological developments. From early candle-lit devices to the modern endoscope, refinements in visualization techniques have made endoscopic skull base surgery (ESBS) a standard practice for treating a variety of conditions. The endoscope has also been integrated with other technologies to enhance visualization, including fluorescence agents, intraoperative neuronavigation with augmented reality, and the exoscope.

View Article and Find Full Text PDF

Objective: In 2017, the United States opioid epidemic was declared a public health emergency. Increased efforts have been made to understand and reduce patient opioid use in neurosurgery. However, the factors associated with postoperative opioid use remain understudied in endoscopic endonasal skull base surgery (EESBS).

View Article and Find Full Text PDF